Back to search

The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in Patients with the G20210A Transition in the Prothrombin Gene

Data up to Jan 2025

Published1999
Citations135
References19

Total Citations Per Year

Abstract

References (19)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Mutation in blood coagulation factor V associated with resistance to activated protein C

1994 • 3,871 citations

A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis

1996 • 3,124 citations

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1996 • 2,090 citations

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

1995 • 1,467 citations

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)

1996 • 1,331 citations

A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism

1995 • 950 citations

Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families

1994 • 446 citations

The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)

1997 • 380 citations

Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S

1995 • 314 citations

The 20210 A Allele of the Prothrombin Gene Is a Common Risk Factor among Swedish Outpatients with Verified Deep Venous Thrombosis

1997 • 255 citations

Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism

1995 • 251 citations

Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency

1996 • 237 citations

The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden

1997 • 206 citations

The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population

1997 • 172 citations

Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.

1992 • 151 citations

Mutation in blood coagulation factor V associated with resistance to activated protein C

1995 • 145 citations

Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families

1994 • 29 citations

Cited By (0)

Loading...
The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in… (1999) – Thrombosis and Haemostasis | Metascience Observatory Explorer